247 results
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
29 May 24
Report of Foreign Private Issuer
7:05am
Exhibit 99.1
Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic Effects on Heart Diseases
Ramat … a scientific review by independent scientists summarizing50 publications from scientists all over the world stating that piclidenoson and namodenoson
6-K
CANF
Can-Fite Biopharma Ltd
29 May 24
Report of Foreign Private Issuer
7:05am
BioPharma Ltd. issued a press release entitled “Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
22 May 24
2024 Annual General Meeting of Shareholders
4:15pm
accounting firm, a member firm of Ernst & Young Global, as our independent registered public accounting firm for the year ending December 31, 2024 … . To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended December 31, 2023
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
13 May 24
Report of Foreign Private Issuer
7:03am
is Israel, Europe and the US. The study is designed to perform an interim analysis by an Independent Data Monitoring Committee (IDMC) upon enrollment
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
25 Apr 24
Current report (foreign)
7:03am
by an Independent Data Monitoring Committee (IDMC) upon enrollment of 50% patients.
Namodenoson has Orphan Drug status with both the FDA and EMA, as well as Fast
S-8
EX-23.1
h96f25q
5 Apr 24
Registration of securities for employees
4:15pm
POS AM
EX-23.1
o98sdaawo
5 Apr 24
Prospectus update (post-effective amendment)
4:15pm
POS AM
c4mp0rjeurrdgyco
5 Apr 24
Prospectus update (post-effective amendment)
4:15pm
F-3/A
nitunbj nox4mti
28 Dec 23
Shelf registration (foreign) (amended)
4:16pm
F-3/A
EX-23.1
pg2asgp6bsu88uyfegg1
28 Dec 23
Shelf registration (foreign) (amended)
4:16pm
F-3
EX-23.1
u4gjp
12 Dec 23
Shelf registration (foreign)
4:15pm
F-3
tjm7 r3k2tn3r6r
12 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-10.2
a8wggesk
22 Nov 23
Report of Foreign Private Issuer
4:15pm
6-K
EX-10.3
ojwcpj 7a7z
22 Nov 23
Report of Foreign Private Issuer
4:15pm
6-K
EX-99.1
nxk1d rqdp
21 Nov 23
Report of Foreign Private Issuer
7:03am
6-K
EX-99.1
l8pqfe5ak31ssryhej
7 Sep 23
Report of Foreign Private Issuer
7:25am
POS AM
EX-23.1
b3a7q b1i4u2tlw
1 Sep 23
Prospectus update (post-effective amendment)
4:16pm